Guru Ownership Trend
Guru Analysis for CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $516.38 M.
Top institutional holders include Catherine Wood and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $40.19 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Cliff Asness reduced exposure by 26.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for CRISPR Therapeutics AG (CRSP)
Major holders include Catherine Wood ($551.78 M), Paul Tudor Jones ($2.07 M), Cliff Asness ($1.09 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 10.59 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $40.19 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited CRSP. The total reported sell value was $423,139.
Yes, 1 managers opened new positions in CRSP, and 1 increased their existing holdings. The total reported buy value was $40.62 M.